Structural Comparison of Infliximab and a Biosimilar via Subunit Analysis Using the Waters Biopharmaceutical Platform with UNIFI
19 Feb 2015

This application note characterizes infliximab and a biosimilar candidate, produced in a different cell line, using Waters Biopharmaceutical Platform Solution. The objective is to screen multiple lots of both the innovator and biosimilar products at the subunit level to establish comparability at this higher level of structure. Lot-to-lot and batch-to-batch comparisons will show product variation, illustrating the range of quality attributes to be considered in a candidate biosimilar.

Show    per page
1 of 10     Page  1 2 3  ... Next 
Adding Mass Detection to Routine Peptide-Level Biotherapeutic Analyses with the ACQUITY QDa Detector Peptides, Biotherapeutics4 Feb 2015Read
Benefits of Using Mass Detection for Analysis of Cetrimonium Bromide Pharmaceutical Raw Material Pharmaceuticals2 Feb 2015Read
Streamlining Analysis of Impurities in the Pharmaceutical Products using Empower 3 ICH Impurity Processing Pharmaceuticals28 Jan 2015Read
Rapid Preparation of Released N-Glycans for HILIC Analysis Using a Novel Fluorescence and MS-Active Labeling Reagent Glycans28 Jan 2015Read
Keys for Enabling Optimum Peptide Characterizations: A Peptide Mapping “How to” Guide Peptide Mapping28 Jan 2015Read
Determine MAb Titers Quickly and Accurately Monoclonal Antibodies28 Jan 2015Read
Future Proofing the Biopharmaceutical QC Lab: Benefits of Automating Mobile Phase Delivery to Improve pH Consistency in Size Exclusion Chromatography Methods Quality Control, Biopharmaceuticals28 Jan 2015Read
Analysis of Glycopeptide Glycoforms in Monoclonal Antibody Tryptic Digest using a UPLC HILIC Column Glycans, Glycosylation28 Jan 2015Read
N-Linked Glycans of Glycoproteins: A New Column for Improved Resolution Glycans26 Jan 2015Read
Development of an UHPLC Method for Azithromycin Tablets Using ChromSword Auto Software Pharmaceuticals22 Jan 2015Read

Popular tags in SelectScience

Buying Guides